Ken Griffin I Specimen Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in I Specimen Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 25,500 shares of ISPC stock, worth $131,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,500Holding current value
$131,325% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ISPC
# of Institutions
13Shares Held
320KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY56.5KShares$291,1700.0% of portfolio
-
Hrt Financial LP New York, NY45.9KShares$236,5650.0% of portfolio
-
Virtu Financial LLC New York, NY42.1KShares$216,7480.0% of portfolio
-
Geode Capital Management, LLC Boston, MA38.5KShares$198,2640.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA36KShares$185,3330.0% of portfolio
About iSpecimen Inc.
- Ticker ISPC
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 8,880,600
- Market Cap $45.7M
- Description
- iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, bioban...